1756-9966
Quarterly
Yes
J EXP CLIN CANC RES
1982
186
ITALY
http://jeccr.biomedcentral.com/
平均1月審稿時(shí)間
約66.66%平均錄用比例
5.646影響因子
腫瘤學(xué)小學(xué)科
《實(shí)驗(yàn)與臨床癌癥研究雜志》尋求包括基礎(chǔ)癌癥研究重大進(jìn)展的手稿,并提供從實(shí)驗(yàn)室到診所的轉(zhuǎn)化橋梁,為理解、預(yù)防、診斷和治療癌癥開辟新途徑。具體的關(guān)注領(lǐng)域包括但不限于:惡性表型和轉(zhuǎn)移性疾病的進(jìn)展機(jī)制;預(yù)測(cè)對(duì)治療的反應(yīng)或抗藥性的分子改變或生物標(biāo)志物;目標(biāo)療法中的翻譯研究;個(gè)性化醫(yī)學(xué);生物信息學(xué)和生物統(tǒng)計(jì)學(xué)的新應(yīng)用;腫瘤免疫治療;人類腫瘤的大規(guī)模分子表征和具有臨床應(yīng)用潛力的創(chuàng)新方法。以下標(biāo)準(zhǔn)概述了該期刊所考慮的研究類型:該研究發(fā)現(xiàn),以前沒有在同一個(gè)腫瘤模型中發(fā)表過。在多個(gè)細(xì)胞系中進(jìn)行的研究。這些結(jié)論并不代表漸進(jìn)的研究結(jié)果。研究包括明確的標(biāo)題和摘要,向非專家傳達(dá)研究的重要性。《實(shí)驗(yàn)與臨床癌癥研究雜志》的在線出現(xiàn)使人們能夠立即發(fā)表可接受的文章,并提供大量數(shù)據(jù)和補(bǔ)充信息,以確保新的研究盡可能高效和迅速地傳播到科學(xué)界。
https://www.editorialmanager.com/jecc/default.aspx
Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.The following criteria provide an overview of the types of studies considered by the journal:Findings that have not been previously published in the same tumor model.Studies performed in multiple cell lines.Conclusions that are not representative of incremental findings.Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會(huì)議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊